News

This startup wants to prove gene-editing embryos is safe for making healthy babies

By Rob Stein, NPR [cites CGS' Katie Hasson] | 09.29.2026

Cathy Tie slips on a white lab coat bearing her name and the logo of her startup: Origin Genomics. "Welcome!" she says as she leads an NPR reporter, photographer and videographer on an exclusive tour of Origin's labs located...

Human Genetic Modification

Demographic Fears and Far-Right Fantasies

By Alexandra Minna Stern, Los Angeles Review of Books | 09.26.2026

This is the 17th installment in the Legacies of Eugenics series, which features essays by leading thinkers devoted to exploring the history of eugenics and the ways it shapes our present. The series is organized by Osagie K. Obasogie in...

Society

She Got a Great Deal on Egg Freezing. Then She Spiraled

By Maia Hibbett, Wired | 09.09.2026

THE INSTAGRAM POST, precision-guided by sex and age, had zeroed in on its target. Yuchen Tu is a conser­vatory-trained viola...

U.S. Federal

Eugenics and the Nihilism of Law-and-Order Politics

By Terence Keel, Los Ángeles Review of Books | 09.06.2026

This is the 16th installment in the Legacies of Eugenics series, which features essays by leading thinkers devoted to exploring...

U.S. States

Stem cell institute, under scrutiny, seeks a leader

By Timothy Roberts, San Jose Business Journal | 01.23.2005
When the committee looking for a president of the California Institute for Regenerative Medicine -- the organization overseeing the state's...
Stem Cells

Stem cell holdings criticized

By Laura Mecoy, Sacramento Bee | 01.21.2005
Ten of the 29 directors of California's new stem cell program serve on biotech or pharmaceutical firms' boards of directors...
Biotech & Pharma

Opinion: Rich Guys With Causes Lack Accountability

By David Wessel, Wall Street Journal | 01.20.2005
The story of the rich man who goes into politics and spends his money to get elected is old and...
Biopolitics

Stem cell panelists show holdings: Economic reports leave some observers uneasy

By Lisa M. Krieger and Paul Jacobs , San Jose Mercury News | 01.19.2005
Robert Klein of Portola Valley, the financier who runs the state's new stem cell research institute, reported that his company...
Biotech & Pharma

Refereeing the Next Big Boom

By Chris Thompson, East Bay Express | 01.19.2005
Say what you will about why Californians voted for the stem-cell research initiative. Whether they genuinely believed in the field's...
Biotech & Pharma

Financier Set to Oversee Stem-Cell Program

By Lisa M. Krieger and Paul Jacobs, San Jose Mercury News | 01.16.2005
Businessman behind Prop. 71 has become powerful player
Mercury News

Faced with a massive federal roadblock to his plans to...
Biotech & Pharma

Guidelines to precede stem cell grants

By Carl T. Hall, San Francisco Chronicle | 01.13.2005
Board chairman says ethical issues will be resolved

Robert N. Klein, chairman of California's new stem cell institute, has moved...
Stem Cells

South Korea approves cloning research

By Agence France-Presse, Agence France-Presse | 01.12.2005

SEOUL (AFP) - South Korea (news - web sites) gave official government backing to ground-breaking research that produced the world's...

Policies